Sign in
Taking peopleNo phase

Platelet-Directed Whole Blood Transfusion Strategy for Malaria

Key facts

Who runs it
Johns Hopkins Bloomberg School of Public Health
Where
Baltimore, United StatesSee the siteAlso in 1 other country, 1 site
Trial code
Status
Recruiting
People taking part
132 people, planned
Started
24 Feb 2024
Expected to end
31 May 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Whole blood transfusion
Record updated
11 September 2026

Who can take part

Age
1 month to 59 months
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Age <5 years
  • Platelet count ≤100,000/uL
  • Hemoglobin >5 and ≤11 g/dL
  • P. falciparum parasitemia ≥500 parasites/uL
  • Diagnosis of severe malaria meeting World Health Organization (WHO) criteria
  • Ability and willingness of the legal guardian to comply with study protocol for the duration of the study
  • Residence within health clinic catchment area
  • Signed informed consent obtained from the parent or legal guardian of the participant

Who cannot take part

  • Presence of any other condition or abnormality which, in the opinion of the investigator, would compromise the safety of the participant or the quality of the data
  • Residence in foster care or children otherwise under government supervision
  • Residence outside the hospital catchment area, or plan to leave the area
  • Any contraindication to whole blood transfusion

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Severe malaria or thrombocytopenia

Where in United States

Also in 1 other country, 1 site

  • Johns Hopkins Bloomberg School of Public HealthBaltimore, United StatesContact: Matthew M Ippolito, MD PhDNo longer taking part

About the trial

What the trial wants to find out

Open-label randomized controlled trial to test the effectiveness of whole blood transfusion for improving survival in children with severe malaria complicated by thrombocytopenia.

The 2 groups in the trial

  • Whole blood transfusionTreatment being tested

    Whole blood transfusion x1 (20 mL/kg)

  • ControlNo study treatment, for comparison

    Standard-of-care

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical and Translational Investigations of Severe Malaria Pathophysiology [Parent Study Protocol]
Criteria questions
Built from NCT05711485, who can take part
Record updated
11 September 2026